Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03583918 · ClinicalTrials.gov registry record · NA

Efficacy of Micro-excisional Skin Removal by Micro-coring Device in Treatment of Wrinkles and Laxity of Face and Neck

A NA study, sponsored by Cytrellis Biosystems.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03583918 is a NA study that has completed, run by Cytrellis Biosystems. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03583918, a NA study, has completed, sponsored by Cytrellis Biosystems.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This is a prospective, multi-center, pilot study evaluating effectiveness of micro-excisional skin remodeling by micro-coring skin in subjects meeting the Inclusion Criteria. Subjects will undergo bilateral treatment on the face and neck (upper and lower cheek, upper and lower lip, periocular and perioral areas, submandibular and middle neck, etc). The exact treatment area(s), choice of treatment density are left to the Investigator's discretion and subject's consent. Up to 3 treatments are allowed with a minimum of 30-day between the consecutive treatments.

Interventions

  • DEVICE HighThroughput Micro Coring Device

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-06-01
Est. Completion 2018-06-13
Phase NA

Sponsor

Cytrellis Biosystems

8 total trials

What the Registry Record Tells You About NCT03583918

The ClinicalTrials.gov registry entry for NCT03583918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cytrellis Biosystems, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which HighThroughput Micro Coring Device is the first listed.

NCT03583918 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03583918 about?

NCT03583918 is a clinical study titled "Efficacy of Micro-excisional Skin Removal by Micro-coring Device in Treatment of Wrinkles and Laxity of Face and Neck". This is a prospective, multi-center, pilot study evaluating effectiveness of micro-excisional skin remodeling by micro-coring skin in subjects meeting the Inclusion Criteria. Subjects will undergo bilateral treatment on the face and neck (upper and lower cheek, upper and lower lip, periocular and pe...

What is the current status of trial NCT03583918?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-06-01. Estimated completion is 2018-06-13.

What interventions are being tested in trial NCT03583918?

The interventions under investigation include: HighThroughput Micro Coring Device (DEVICE).

Who is sponsoring clinical trial NCT03583918?

This trial is sponsored by Cytrellis Biosystems, which has 8 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.